12,500,000 Shares ANTARES PHARMA, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • May 13th, 2011 • Antares Pharma, Inc. • Surgical & medical instruments & apparatus • New York
The Company has prepared and filed in conformity with the requirements of the Securities Act of 1933, as amended (the “Securities Act”), and the published rules and regulations thereunder (the “Rules”) adopted by the Securities and Exchange Commission (the “Commission”) a “shelf” registration statement on Form S-3 (No. 333-167975), which became effective as of July 21, 2010, including a base prospectus (the “Base Prospectus”) relating to common stock, preferred stock and warrants of the Company that may be sold from time to time by the Company in accordance with Rule 415 of the Securities Act, and such amendments thereof as may have been required to the date of this Agreement. Copies of such Registration Statement (including all amendments thereof and all documents deemed incorporated by reference therein) and of the related Base Prospectus have heretofore been delivered by the Company or are otherwise available to you.
